loader
Please Wait
Applying Filters...
menu
    • menu

    Looking for Tox21_202741? Find Granulation used in Tox21_202741 to address drug delivery challenges on PharmaCompass.

    Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

    Virtual Booth

    Contact Supplier

    View Presentation

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    Menu

    Tox21_202741

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1Xls

    Filters

    clear-filterReset all filters
    Client Email Product
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 8BASF

    02 1Ingredion Pharma Solutions

    03 1Microlex e.U

    04 2Pharmatrans-Sanaq

    05 1Prachin Chemical

    06 4Sigachi Industries

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass

    01

    Sigachi Industries

    ACECEL

    arrow
    AAPS 2024
    Not Confirmed

    02

    Prachin Chemical

    PARCROS

    arrow
    AAPS 2024
    Not Confirmed

    03

    Sigachi Industries

    HICEL

    arrow
    AAPS 2024
    Not Confirmed

    04

    Ingredion Pharma Solutions

    UNI-PURE WG 220

    arrow
    AAPS 2024
    Not Confirmed

    05

    Pharmatrans-Sanaq

    MCC SANAQ

    arrow
    AAPS 2024
    Not Confirmed

    Pharmatrans-Sanaq

    Switzerland
    arrow
    AAPS 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Capsule, Tablet

    Grade : Oral

    Brand Name : MCC SANAQ

    Application : Fillers, Diluents & Binders, Granulation

    Excipient Details : Microcrystalline Cellulose is mainly used as filling, binding and blasting material for tablets (direct tableting), as well as for dry and wet granulation and as filling material for hard gelatin capsules.

    Pharmacopoeia Ref : EP./USP.NF

    Technical Specs : NA

    Ingredient(s) : Microcrystalline Cellulose

    Dosage Form : Capsule, Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Microcrystalline Cellulose

    Dosage Form : Capsule, Tablet

    Category : Fillers, Diluents & Binders, Granulation

    Brand : MCC SANAQ

    Applications : Microcrystalline Cellulose is mainly used as filling, binding and blasting material for tablets (direct tableting), as well as for dry and wet granulation and as filling material for hard gelatin capsules.

    Pharmacopoeia Ref : EP./USP.NF

    Technical Specs : NA

    Grade : Oral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    06

    Sigachi Industries

    HILOSE

    arrow
    AAPS 2024
    Not Confirmed

    07

    Sigachi Industries

    HICELLAC

    arrow
    AAPS 2024
    Not Confirmed

    Sigachi Industries

    India
    arrow
    AAPS 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Tablet

    Grade : Oral

    Brand Name : HiCellac

    Application : Direct Compression, Granulation

    Excipient Details : HiCellac 100 is used in direct compression, dry granulation & capsule filling, suitable for low dose formulations where API content uniformity is critical. It also provides excellent compaction properties & tablet hardness.

    Pharmacopoeia Ref :

    Technical Specs :

    Ingredient(s) : Lactose Monohydrate, Microcrystalline Cellulose

    Dosage Form : Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Lactose Monohydrate, Microcrystalline Cellulose

    Dosage Form : Tablet

    Category : Direct Compression, Granulation

    Brand : HICELLAC

    Applications : HiCellac 100 is used in direct compression, dry granulation & capsule filling, suitable for low dose formulations where API content uniformity is critical. It also provides excellent compaction properties & tablet hardness.

    Pharmacopoeia Ref : Not Available

    Technical Specs : Not Available

    Grade : Oral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    08

    Microlex e.U

    MICROLEX® MCC 101

    arrow
    AAPS 2024
    Not Confirmed

    09

    BASF

    KOLLIWAX S FINE

    arrow
    AAPS 2024
    Not Confirmed

    BASF

    Germany
    arrow
    AAPS 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Capsule, Granule / Pellet, Suppository, Tablet

    Grade :

    Brand Name : Kolliwax S Fine

    Application : Direct Compression, Granulation, Lubricants & Glidants

    Excipient Details : Lipophilic lubricant, especially for sensitive acidic APIs. Matrix forming agent in sustained-release dosage forms, emulsifying and solubilizing agent in topical formulations and hardening agent in glycerin suppositories

    Pharmacopoeia Ref :

    Technical Specs :

    Ingredient(s) : Palmitic Acid, Stearic Acid

    Dosage Form : Capsule, Granule / Pellet, Suppository, Tablet

    Grade :

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Palmitic Acid, Stearic Acid

    Dosage Form : Capsule, Granule / Pellet, Suppository, Tablet

    Category : Direct Compression, Granulation, Lubricants & Glidants

    Brand : KOLLIWAX S FINE

    Applications : Lipophilic lubricant, especially for sensitive acidic APIs. Matrix forming agent in sustained-release dosage forms, emulsifying and solubilizing agent in topical formulations and hardening agent in glycerin suppositories

    Pharmacopoeia Ref : Not Available

    Technical Specs : Not Available

    Grade : Not Available

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    10

    BASF

    SOLUPLUS

    arrow
    AAPS 2024
    Not Confirmed

    BASF

    Germany
    arrow
    AAPS 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Solution, Tablet, Topical Film, Transdermal Patch

    Grade :

    Brand Name : Soluplus

    Application : Controlled & Modified Release, Granulation, Solubilizers

    Excipient Details : Solubility and bioavailability enhancement, ideal for hot melt extrusion (HME)

    Pharmacopoeia Ref : Polyvinyl caprolactam – poly...

    Technical Specs :

    Ingredient(s) : polyethylene glycol, Polyvinyl Acetate

    Dosage Form : Solution, Tablet, Topical Film, Transdermal Patch

    Grade :

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : polyethylene glycol, Polyvinyl Acetate

    Dosage Form : Solution, Tablet, Topical Film, Transdermal Patch

    Category : Controlled & Modified Release, Granulation, Solubilizers

    Brand : SOLUPLUS

    Applications : Solubility and bioavailability enhancement, ideal for hot melt extrusion (HME)

    Pharmacopoeia Ref : Polyvinyl caprolactam – polyvinyl acetate – polyethylene glycol graft copolymer

    Technical Specs : Not Available

    Grade : Not Available

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth